What does a high-fat diet do to your gut microbiome?
A high-fat diet noticeably disrupts the gut microbiome: less bacterial diversity, more harmful species and a leaky gut wall that fuels low-grade inflammation. That relationship is consistent in animal research and plausible in humans, so if you want to protect your gut health, it pays to keep an eye on the proportion of fat in your diet.
A high-fat diet (in which more than 40% of calories come from fat) reduces the variety of bacterial species in your gut. Fewer species means a less resilient digestive system. The ratio between two major bacterial groups shifts: Firmicutes increase relative to Bacteroidetes. This pattern has been found in both animal studies and in people, in a large dietary dataset with more than 3,800 participants.
With that shift, protective bacterial species disappear while potentially harmful species gain more ground. Researchers call this dysbiosis: a disrupted balance in the gut microbiome. At the same time, the gut wall becomes damaged and a 'leaky gut' develops. Toxic bacterial products then seep through the wall into the bloodstream and trigger low-grade, chronic inflammation throughout the body. This so-called metabolic endotoxemia is a risk factor for type 2 diabetes, cardiovascular disease and obesity.
In mouse studies, the same dysbiosis also led to fatty liver, oxidative stress and liver inflammation. When the gut microbiome was restored, that liver damage decreased. This confirms the role of the gut microbiome as a link between high-fat eating and organ damage, although this has not yet been demonstrated directly in humans.
For colorectal cancer too, mouse studies point to a connection: a high-fat diet promoted tumour growth via gut microbiome disruptions, and that tumour growth decreased once the microbiome was eliminated with antibiotics. Another mechanism, also in mice, shows that the altered gut microbiome produces more of the amino acid leucine. In women with breast cancer, a higher leucine level was associated with more immune-suppressing cells, which predicted worse outcomes. This is associative and experimental: causal evidence in humans is still lacking here.
Most findings come from mouse research and observational studies in humans. There are no large randomised studies that directly demonstrate cause and effect in humans. The dysbiosis, leaky gut and inflammatory pathways are considered probably causal on the basis of consistent animal and association data. The cancer-immune pathway is the least mature part of the evidence.